Kimball, A. B., Clowse, M. E. B., Scheuerle, A. E., Chambers, C., Afzali, A., Cush, J. J., … Forger, F. (2018). Characteristics and outcomes of pregnancies exposed to certolizumab pegol prospectively reported to a safety database. In Journal of the American Academy of Dermatology (Vol. 79, pp. AB68–AB68). San Diego, CA: MOSBY-ELSEVIER.

Kimball, Alexa B., Megan E. B. Clowse, Angela E. Scheuerle, Christina Chambers, Anita Afzali, John J. Cush, Maureen Cooney, Laura Shauhnessy, Mark Vanderkelen, and Frauke Forger. “Characteristics and outcomes of pregnancies exposed to certolizumab pegol prospectively reported to a safety database.” In Journal of the American Academy of Dermatology, 79:AB68–AB68. MOSBY-ELSEVIER, 2018.

Kimball AB, Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Cush JJ, et al. Characteristics and outcomes of pregnancies exposed to certolizumab pegol prospectively reported to a safety database. In: Journal of the American Academy of Dermatology. MOSBY-ELSEVIER; 2018. p. AB68–AB68.

Kimball, Alexa B., et al. “Characteristics and outcomes of pregnancies exposed to certolizumab pegol prospectively reported to a safety database.” Journal of the American Academy of Dermatology, vol. 79, no. 3, MOSBY-ELSEVIER, 2018, pp. AB68–AB68.

Kimball AB, Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Cush JJ, Cooney M, Shauhnessy L, Vanderkelen M, Forger F. Characteristics and outcomes of pregnancies exposed to certolizumab pegol prospectively reported to a safety database. Journal of the American Academy of Dermatology. MOSBY-ELSEVIER; 2018. p. AB68–AB68.